Acute Dystonia Associated with Fluvoxamine—Metoclopramide

Finley PR . Selective serotonin reuptake inhibitors: Pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 1994;28: 1359–69.

Mitchell PB . Selective serotonin reuptake inhibitors: Adverse effects, toxicity and interactions. Adverse Drug React Toxicol Rev 1994;13: 121–44.

Caley CF . Extrapyramidal reactions and the selective serotonin-reuptake inhibitors. Ann Pharmacother 1997;31: 1481–9.

Díez-Espino J Ibanez-Mora L Fandos-Oloma JMa Mundet-Tuduri X Ferran-Mercadé M Bundó-Vidiella M . Reacciones distónicas secundarias al uso de ortopramidas: Presentación de 22 casos. Aten Primaria 1987;4: 145–7.

Benfield P Ward A . Fluvoxamine. A review of its pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986;32: 313–34.

Mitchell PB . Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf 1997;17: 390–406.

Brunton LL . Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Hardman JG Limbird LE Molinoff PB Ruddon RW Gilman A Goodman , eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 917–36.